Medication
Jamp Diltiazem T
DIN 02495392 · Jamp Pharma Corporation Likely a generic
What it is
- Active ingredients
- Diltiazem Hydrochloride — 240 mg
- Form and route
- Capsule (Extended-Release) · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2021-07-03
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Apo-Diltiaz CD
- Tiazac
- Teva-Diltiazem CD
- Tiazac XC
- Teva-Diltiazem T
- Diltiazem CD
- Teva-Diltiazem XC
- Diltiazem CD
- Mar-Diltiazem T
- Mar-Diltiazem CD
- Diltiazem T
- Jamp Diltiazem CD
- Pro-Diltiazem CD
- M-Diltiazem CD
- M-Diltiazem T
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Cardiovascular system
- ATC code
- C08DB01
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of C08DB01, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.